BMC CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2366039, encodeId=27202366039d9, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：傻鸟杂志一审审了9个月，5个审稿人意见加起来有5000字, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d255482563, createdName=ms4000000366935454, createdTime=Wed Sep 09 14:11:03 CST 2026, time=2026-09-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2353301, encodeId=42a42353301ab, content=给了大修，修改后多久给决定意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Aug 06 19:43:00 CST 2026, time=2026-08-06, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2292693, encodeId=c508229269364, content=BMC接收纯生信的文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84649148489, createdName=ms8000000335270410, createdTime=Wed Dec 10 16:14:55 CST 2025, time=2025-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2341974, encodeId=b2c923419e483, content=审稿速度:12.0 偏重的研究方向：胃癌;微创手术 经验分享：想问下近期有人投BMC Cancer的ARTICLE吗？投了一篇胃癌手术相关的文章，7个月一审还没回来，发邮件每次回复的差不多，这个情况有什么建议吗？以前投过一次，也是审稿比较慢，但是半年的时候接收了，这个感觉太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Mon Jul 13 10:48:50 CST 2026, time=2026-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2310645, encodeId=e4d5231064589, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：meta分析还是蛮快的，感觉还是挺看文章方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90cc8530029, createdName=ms2000002074391176, createdTime=Wed May 06 21:22:59 CST 2026, time=2026-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2300952, encodeId=84c6230095278, content=偏重的研究方向：肿瘤 经验分享：效率低下的令人发指, peer review三个月没人接受审稿。跟编辑部发邮件（我还是用工作邮箱发的）,每次就是打太极, 道歉态度倒是很诚恳。推荐了reviewer过去也不处理。准备再等半个月就撤稿了。这杂志要是这么搞下去真的要完蛋了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Wed Feb 18 06:52:18 CST 2026, time=2026-02-18, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2286260, encodeId=5f4a22862605c, content=我投的这个杂志，2月投稿的，现在第三次外审，快9个月了。第三次只有一个审稿人。前两次都是大修。还能录取吗，等毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69d8427178, createdName=ms3000000454772838, createdTime=Sun Oct 26 21:51:54 CST 2025, time=2025-10-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2287004, encodeId=83c0228e00440, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信;干湿结合 经验分享：这个期刊真恶心，初审还让我改这改那的，又得上传原始数据到公共数据库，搞完返回去跟我说，文章被编辑部评估发表的优先度低拒稿了。你早点拒稿呀，让我搞这么多事干嘛，傻逼杂志，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb365528709, createdName=ms6000000058422661, createdTime=Fri Oct 31 19:17:36 CST 2025, time=2025-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2284369, encodeId=d97022843695f, content=不收BIB，拒稿邮件：BMC Cancer does not consider bibliometric analyses and therefore we cannot consider your manuscript for peer review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Sat Oct 11 11:14:20 CST 2025, time=2025-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269179, encodeId=ad8222691e90f, content=我这里的经验是peer review一个月后第一个审稿人接收，前面挺快的。看后面吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Jun 13 14:23:29 CST 2025, time=2025-06-13, status=1, ipAttribution=重庆)]

2026-09-09 ms4000000366935454 来自浙江省

审稿速度:12.0 | 投稿命中率:25.0
经验分享：傻鸟杂志一审审了9个月，5个审稿人意见加起来有5000字

2 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2366039, encodeId=27202366039d9, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：傻鸟杂志一审审了9个月，5个审稿人意见加起来有5000字, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d255482563, createdName=ms4000000366935454, createdTime=Wed Sep 09 14:11:03 CST 2026, time=2026-09-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2353301, encodeId=42a42353301ab, content=给了大修，修改后多久给决定意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Aug 06 19:43:00 CST 2026, time=2026-08-06, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2292693, encodeId=c508229269364, content=BMC接收纯生信的文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84649148489, createdName=ms8000000335270410, createdTime=Wed Dec 10 16:14:55 CST 2025, time=2025-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2341974, encodeId=b2c923419e483, content=审稿速度:12.0 偏重的研究方向：胃癌;微创手术 经验分享：想问下近期有人投BMC Cancer的ARTICLE吗？投了一篇胃癌手术相关的文章，7个月一审还没回来，发邮件每次回复的差不多，这个情况有什么建议吗？以前投过一次，也是审稿比较慢，但是半年的时候接收了，这个感觉太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Mon Jul 13 10:48:50 CST 2026, time=2026-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2310645, encodeId=e4d5231064589, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：meta分析还是蛮快的，感觉还是挺看文章方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90cc8530029, createdName=ms2000002074391176, createdTime=Wed May 06 21:22:59 CST 2026, time=2026-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2300952, encodeId=84c6230095278, content=偏重的研究方向：肿瘤 经验分享：效率低下的令人发指, peer review三个月没人接受审稿。跟编辑部发邮件（我还是用工作邮箱发的）,每次就是打太极, 道歉态度倒是很诚恳。推荐了reviewer过去也不处理。准备再等半个月就撤稿了。这杂志要是这么搞下去真的要完蛋了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Wed Feb 18 06:52:18 CST 2026, time=2026-02-18, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2286260, encodeId=5f4a22862605c, content=我投的这个杂志，2月投稿的，现在第三次外审，快9个月了。第三次只有一个审稿人。前两次都是大修。还能录取吗，等毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69d8427178, createdName=ms3000000454772838, createdTime=Sun Oct 26 21:51:54 CST 2025, time=2025-10-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2287004, encodeId=83c0228e00440, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信;干湿结合 经验分享：这个期刊真恶心，初审还让我改这改那的，又得上传原始数据到公共数据库，搞完返回去跟我说，文章被编辑部评估发表的优先度低拒稿了。你早点拒稿呀，让我搞这么多事干嘛，傻逼杂志，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb365528709, createdName=ms6000000058422661, createdTime=Fri Oct 31 19:17:36 CST 2025, time=2025-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2284369, encodeId=d97022843695f, content=不收BIB，拒稿邮件：BMC Cancer does not consider bibliometric analyses and therefore we cannot consider your manuscript for peer review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Sat Oct 11 11:14:20 CST 2025, time=2025-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269179, encodeId=ad8222691e90f, content=我这里的经验是peer review一个月后第一个审稿人接收，前面挺快的。看后面吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Jun 13 14:23:29 CST 2025, time=2025-06-13, status=1, ipAttribution=重庆)]

2026-08-06 ms3000001126828781 来自广西

给了大修，修改后多久给决定意见啊

13 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2366039, encodeId=27202366039d9, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：傻鸟杂志一审审了9个月，5个审稿人意见加起来有5000字, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d255482563, createdName=ms4000000366935454, createdTime=Wed Sep 09 14:11:03 CST 2026, time=2026-09-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2353301, encodeId=42a42353301ab, content=给了大修，修改后多久给决定意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Aug 06 19:43:00 CST 2026, time=2026-08-06, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2292693, encodeId=c508229269364, content=BMC接收纯生信的文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84649148489, createdName=ms8000000335270410, createdTime=Wed Dec 10 16:14:55 CST 2025, time=2025-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2341974, encodeId=b2c923419e483, content=审稿速度:12.0 偏重的研究方向：胃癌;微创手术 经验分享：想问下近期有人投BMC Cancer的ARTICLE吗？投了一篇胃癌手术相关的文章，7个月一审还没回来，发邮件每次回复的差不多，这个情况有什么建议吗？以前投过一次，也是审稿比较慢，但是半年的时候接收了，这个感觉太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Mon Jul 13 10:48:50 CST 2026, time=2026-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2310645, encodeId=e4d5231064589, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：meta分析还是蛮快的，感觉还是挺看文章方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90cc8530029, createdName=ms2000002074391176, createdTime=Wed May 06 21:22:59 CST 2026, time=2026-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2300952, encodeId=84c6230095278, content=偏重的研究方向：肿瘤 经验分享：效率低下的令人发指, peer review三个月没人接受审稿。跟编辑部发邮件（我还是用工作邮箱发的）,每次就是打太极, 道歉态度倒是很诚恳。推荐了reviewer过去也不处理。准备再等半个月就撤稿了。这杂志要是这么搞下去真的要完蛋了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Wed Feb 18 06:52:18 CST 2026, time=2026-02-18, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2286260, encodeId=5f4a22862605c, content=我投的这个杂志，2月投稿的，现在第三次外审，快9个月了。第三次只有一个审稿人。前两次都是大修。还能录取吗，等毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69d8427178, createdName=ms3000000454772838, createdTime=Sun Oct 26 21:51:54 CST 2025, time=2025-10-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2287004, encodeId=83c0228e00440, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信;干湿结合 经验分享：这个期刊真恶心，初审还让我改这改那的，又得上传原始数据到公共数据库，搞完返回去跟我说，文章被编辑部评估发表的优先度低拒稿了。你早点拒稿呀，让我搞这么多事干嘛，傻逼杂志，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb365528709, createdName=ms6000000058422661, createdTime=Fri Oct 31 19:17:36 CST 2025, time=2025-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2284369, encodeId=d97022843695f, content=不收BIB，拒稿邮件：BMC Cancer does not consider bibliometric analyses and therefore we cannot consider your manuscript for peer review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Sat Oct 11 11:14:20 CST 2025, time=2025-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269179, encodeId=ad8222691e90f, content=我这里的经验是peer review一个月后第一个审稿人接收，前面挺快的。看后面吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Jun 13 14:23:29 CST 2025, time=2025-06-13, status=1, ipAttribution=重庆)]

2025-12-10 ms8000000335270410 来自河南省

BMC接收纯生信的文章吗

101 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2366039, encodeId=27202366039d9, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：傻鸟杂志一审审了9个月，5个审稿人意见加起来有5000字, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d255482563, createdName=ms4000000366935454, createdTime=Wed Sep 09 14:11:03 CST 2026, time=2026-09-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2353301, encodeId=42a42353301ab, content=给了大修，修改后多久给决定意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Aug 06 19:43:00 CST 2026, time=2026-08-06, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2292693, encodeId=c508229269364, content=BMC接收纯生信的文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84649148489, createdName=ms8000000335270410, createdTime=Wed Dec 10 16:14:55 CST 2025, time=2025-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2341974, encodeId=b2c923419e483, content=审稿速度:12.0 偏重的研究方向：胃癌;微创手术 经验分享：想问下近期有人投BMC Cancer的ARTICLE吗？投了一篇胃癌手术相关的文章，7个月一审还没回来，发邮件每次回复的差不多，这个情况有什么建议吗？以前投过一次，也是审稿比较慢，但是半年的时候接收了，这个感觉太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Mon Jul 13 10:48:50 CST 2026, time=2026-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2310645, encodeId=e4d5231064589, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：meta分析还是蛮快的，感觉还是挺看文章方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90cc8530029, createdName=ms2000002074391176, createdTime=Wed May 06 21:22:59 CST 2026, time=2026-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2300952, encodeId=84c6230095278, content=偏重的研究方向：肿瘤 经验分享：效率低下的令人发指, peer review三个月没人接受审稿。跟编辑部发邮件（我还是用工作邮箱发的）,每次就是打太极, 道歉态度倒是很诚恳。推荐了reviewer过去也不处理。准备再等半个月就撤稿了。这杂志要是这么搞下去真的要完蛋了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Wed Feb 18 06:52:18 CST 2026, time=2026-02-18, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2286260, encodeId=5f4a22862605c, content=我投的这个杂志，2月投稿的，现在第三次外审，快9个月了。第三次只有一个审稿人。前两次都是大修。还能录取吗，等毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69d8427178, createdName=ms3000000454772838, createdTime=Sun Oct 26 21:51:54 CST 2025, time=2025-10-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2287004, encodeId=83c0228e00440, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信;干湿结合 经验分享：这个期刊真恶心，初审还让我改这改那的，又得上传原始数据到公共数据库，搞完返回去跟我说，文章被编辑部评估发表的优先度低拒稿了。你早点拒稿呀，让我搞这么多事干嘛，傻逼杂志，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb365528709, createdName=ms6000000058422661, createdTime=Fri Oct 31 19:17:36 CST 2025, time=2025-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2284369, encodeId=d97022843695f, content=不收BIB，拒稿邮件：BMC Cancer does not consider bibliometric analyses and therefore we cannot consider your manuscript for peer review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Sat Oct 11 11:14:20 CST 2025, time=2025-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269179, encodeId=ad8222691e90f, content=我这里的经验是peer review一个月后第一个审稿人接收，前面挺快的。看后面吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Jun 13 14:23:29 CST 2025, time=2025-06-13, status=1, ipAttribution=重庆)]

2026-07-13 ms9000001935138113 来自北京

审稿速度:12.0
偏重的研究方向：胃癌;微创手术
经验分享：想问下近期有人投BMC Cancer的ARTICLE吗？投了一篇胃癌手术相关的文章，7个月一审还没回来，发邮件每次回复的差不多，这个情况有什么建议吗？以前投过一次，也是审稿比较慢，但是半年的时候接收了，这个感觉太慢了

22 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2366039, encodeId=27202366039d9, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：傻鸟杂志一审审了9个月，5个审稿人意见加起来有5000字, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d255482563, createdName=ms4000000366935454, createdTime=Wed Sep 09 14:11:03 CST 2026, time=2026-09-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2353301, encodeId=42a42353301ab, content=给了大修，修改后多久给决定意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Aug 06 19:43:00 CST 2026, time=2026-08-06, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2292693, encodeId=c508229269364, content=BMC接收纯生信的文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84649148489, createdName=ms8000000335270410, createdTime=Wed Dec 10 16:14:55 CST 2025, time=2025-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2341974, encodeId=b2c923419e483, content=审稿速度:12.0 偏重的研究方向：胃癌;微创手术 经验分享：想问下近期有人投BMC Cancer的ARTICLE吗？投了一篇胃癌手术相关的文章，7个月一审还没回来，发邮件每次回复的差不多，这个情况有什么建议吗？以前投过一次，也是审稿比较慢，但是半年的时候接收了，这个感觉太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Mon Jul 13 10:48:50 CST 2026, time=2026-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2310645, encodeId=e4d5231064589, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：meta分析还是蛮快的，感觉还是挺看文章方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90cc8530029, createdName=ms2000002074391176, createdTime=Wed May 06 21:22:59 CST 2026, time=2026-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2300952, encodeId=84c6230095278, content=偏重的研究方向：肿瘤 经验分享：效率低下的令人发指, peer review三个月没人接受审稿。跟编辑部发邮件（我还是用工作邮箱发的）,每次就是打太极, 道歉态度倒是很诚恳。推荐了reviewer过去也不处理。准备再等半个月就撤稿了。这杂志要是这么搞下去真的要完蛋了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Wed Feb 18 06:52:18 CST 2026, time=2026-02-18, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2286260, encodeId=5f4a22862605c, content=我投的这个杂志，2月投稿的，现在第三次外审，快9个月了。第三次只有一个审稿人。前两次都是大修。还能录取吗，等毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69d8427178, createdName=ms3000000454772838, createdTime=Sun Oct 26 21:51:54 CST 2025, time=2025-10-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2287004, encodeId=83c0228e00440, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信;干湿结合 经验分享：这个期刊真恶心，初审还让我改这改那的，又得上传原始数据到公共数据库，搞完返回去跟我说，文章被编辑部评估发表的优先度低拒稿了。你早点拒稿呀，让我搞这么多事干嘛，傻逼杂志，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb365528709, createdName=ms6000000058422661, createdTime=Fri Oct 31 19:17:36 CST 2025, time=2025-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2284369, encodeId=d97022843695f, content=不收BIB，拒稿邮件：BMC Cancer does not consider bibliometric analyses and therefore we cannot consider your manuscript for peer review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Sat Oct 11 11:14:20 CST 2025, time=2025-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269179, encodeId=ad8222691e90f, content=我这里的经验是peer review一个月后第一个审稿人接收，前面挺快的。看后面吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Jun 13 14:23:29 CST 2025, time=2025-06-13, status=1, ipAttribution=重庆)]

2026-05-06 ms2000002074391176 来自天津

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：meta分析还是蛮快的，感觉还是挺看文章方向的

50 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2366039, encodeId=27202366039d9, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：傻鸟杂志一审审了9个月，5个审稿人意见加起来有5000字, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d255482563, createdName=ms4000000366935454, createdTime=Wed Sep 09 14:11:03 CST 2026, time=2026-09-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2353301, encodeId=42a42353301ab, content=给了大修，修改后多久给决定意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Aug 06 19:43:00 CST 2026, time=2026-08-06, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2292693, encodeId=c508229269364, content=BMC接收纯生信的文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84649148489, createdName=ms8000000335270410, createdTime=Wed Dec 10 16:14:55 CST 2025, time=2025-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2341974, encodeId=b2c923419e483, content=审稿速度:12.0 偏重的研究方向：胃癌;微创手术 经验分享：想问下近期有人投BMC Cancer的ARTICLE吗？投了一篇胃癌手术相关的文章，7个月一审还没回来，发邮件每次回复的差不多，这个情况有什么建议吗？以前投过一次，也是审稿比较慢，但是半年的时候接收了，这个感觉太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Mon Jul 13 10:48:50 CST 2026, time=2026-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2310645, encodeId=e4d5231064589, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：meta分析还是蛮快的，感觉还是挺看文章方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90cc8530029, createdName=ms2000002074391176, createdTime=Wed May 06 21:22:59 CST 2026, time=2026-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2300952, encodeId=84c6230095278, content=偏重的研究方向：肿瘤 经验分享：效率低下的令人发指, peer review三个月没人接受审稿。跟编辑部发邮件（我还是用工作邮箱发的）,每次就是打太极, 道歉态度倒是很诚恳。推荐了reviewer过去也不处理。准备再等半个月就撤稿了。这杂志要是这么搞下去真的要完蛋了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Wed Feb 18 06:52:18 CST 2026, time=2026-02-18, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2286260, encodeId=5f4a22862605c, content=我投的这个杂志，2月投稿的，现在第三次外审，快9个月了。第三次只有一个审稿人。前两次都是大修。还能录取吗，等毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69d8427178, createdName=ms3000000454772838, createdTime=Sun Oct 26 21:51:54 CST 2025, time=2025-10-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2287004, encodeId=83c0228e00440, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信;干湿结合 经验分享：这个期刊真恶心，初审还让我改这改那的，又得上传原始数据到公共数据库，搞完返回去跟我说，文章被编辑部评估发表的优先度低拒稿了。你早点拒稿呀，让我搞这么多事干嘛，傻逼杂志，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb365528709, createdName=ms6000000058422661, createdTime=Fri Oct 31 19:17:36 CST 2025, time=2025-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2284369, encodeId=d97022843695f, content=不收BIB，拒稿邮件：BMC Cancer does not consider bibliometric analyses and therefore we cannot consider your manuscript for peer review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Sat Oct 11 11:14:20 CST 2025, time=2025-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269179, encodeId=ad8222691e90f, content=我这里的经验是peer review一个月后第一个审稿人接收，前面挺快的。看后面吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Jun 13 14:23:29 CST 2025, time=2025-06-13, status=1, ipAttribution=重庆)]

2026-02-18 ms3000000209605964 来自荷兰

偏重的研究方向：肿瘤
经验分享：效率低下的令人发指, peer review三个月没人接受审稿。跟编辑部发邮件（我还是用工作邮箱发的）,每次就是打太极, 道歉态度倒是很诚恳。推荐了reviewer过去也不处理。准备再等半个月就撤稿了。这杂志要是这么搞下去真的要完蛋了

129 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2366039, encodeId=27202366039d9, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：傻鸟杂志一审审了9个月，5个审稿人意见加起来有5000字, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d255482563, createdName=ms4000000366935454, createdTime=Wed Sep 09 14:11:03 CST 2026, time=2026-09-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2353301, encodeId=42a42353301ab, content=给了大修，修改后多久给决定意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Aug 06 19:43:00 CST 2026, time=2026-08-06, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2292693, encodeId=c508229269364, content=BMC接收纯生信的文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84649148489, createdName=ms8000000335270410, createdTime=Wed Dec 10 16:14:55 CST 2025, time=2025-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2341974, encodeId=b2c923419e483, content=审稿速度:12.0 偏重的研究方向：胃癌;微创手术 经验分享：想问下近期有人投BMC Cancer的ARTICLE吗？投了一篇胃癌手术相关的文章，7个月一审还没回来，发邮件每次回复的差不多，这个情况有什么建议吗？以前投过一次，也是审稿比较慢，但是半年的时候接收了，这个感觉太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Mon Jul 13 10:48:50 CST 2026, time=2026-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2310645, encodeId=e4d5231064589, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：meta分析还是蛮快的，感觉还是挺看文章方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90cc8530029, createdName=ms2000002074391176, createdTime=Wed May 06 21:22:59 CST 2026, time=2026-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2300952, encodeId=84c6230095278, content=偏重的研究方向：肿瘤 经验分享：效率低下的令人发指, peer review三个月没人接受审稿。跟编辑部发邮件（我还是用工作邮箱发的）,每次就是打太极, 道歉态度倒是很诚恳。推荐了reviewer过去也不处理。准备再等半个月就撤稿了。这杂志要是这么搞下去真的要完蛋了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Wed Feb 18 06:52:18 CST 2026, time=2026-02-18, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2286260, encodeId=5f4a22862605c, content=我投的这个杂志，2月投稿的，现在第三次外审，快9个月了。第三次只有一个审稿人。前两次都是大修。还能录取吗，等毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69d8427178, createdName=ms3000000454772838, createdTime=Sun Oct 26 21:51:54 CST 2025, time=2025-10-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2287004, encodeId=83c0228e00440, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信;干湿结合 经验分享：这个期刊真恶心，初审还让我改这改那的，又得上传原始数据到公共数据库，搞完返回去跟我说，文章被编辑部评估发表的优先度低拒稿了。你早点拒稿呀，让我搞这么多事干嘛，傻逼杂志，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb365528709, createdName=ms6000000058422661, createdTime=Fri Oct 31 19:17:36 CST 2025, time=2025-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2284369, encodeId=d97022843695f, content=不收BIB，拒稿邮件：BMC Cancer does not consider bibliometric analyses and therefore we cannot consider your manuscript for peer review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Sat Oct 11 11:14:20 CST 2025, time=2025-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269179, encodeId=ad8222691e90f, content=我这里的经验是peer review一个月后第一个审稿人接收，前面挺快的。看后面吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Jun 13 14:23:29 CST 2025, time=2025-06-13, status=1, ipAttribution=重庆)]

2025-10-26 ms3000000454772838 来自河北省

我投的这个杂志，2月投稿的，现在第三次外审，快9个月了。第三次只有一个审稿人。前两次都是大修。还能录取吗，等毕业啊

111 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2366039, encodeId=27202366039d9, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：傻鸟杂志一审审了9个月，5个审稿人意见加起来有5000字, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d255482563, createdName=ms4000000366935454, createdTime=Wed Sep 09 14:11:03 CST 2026, time=2026-09-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2353301, encodeId=42a42353301ab, content=给了大修，修改后多久给决定意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Aug 06 19:43:00 CST 2026, time=2026-08-06, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2292693, encodeId=c508229269364, content=BMC接收纯生信的文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84649148489, createdName=ms8000000335270410, createdTime=Wed Dec 10 16:14:55 CST 2025, time=2025-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2341974, encodeId=b2c923419e483, content=审稿速度:12.0 偏重的研究方向：胃癌;微创手术 经验分享：想问下近期有人投BMC Cancer的ARTICLE吗？投了一篇胃癌手术相关的文章，7个月一审还没回来，发邮件每次回复的差不多，这个情况有什么建议吗？以前投过一次，也是审稿比较慢，但是半年的时候接收了，这个感觉太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Mon Jul 13 10:48:50 CST 2026, time=2026-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2310645, encodeId=e4d5231064589, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：meta分析还是蛮快的，感觉还是挺看文章方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90cc8530029, createdName=ms2000002074391176, createdTime=Wed May 06 21:22:59 CST 2026, time=2026-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2300952, encodeId=84c6230095278, content=偏重的研究方向：肿瘤 经验分享：效率低下的令人发指, peer review三个月没人接受审稿。跟编辑部发邮件（我还是用工作邮箱发的）,每次就是打太极, 道歉态度倒是很诚恳。推荐了reviewer过去也不处理。准备再等半个月就撤稿了。这杂志要是这么搞下去真的要完蛋了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Wed Feb 18 06:52:18 CST 2026, time=2026-02-18, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2286260, encodeId=5f4a22862605c, content=我投的这个杂志，2月投稿的，现在第三次外审，快9个月了。第三次只有一个审稿人。前两次都是大修。还能录取吗，等毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69d8427178, createdName=ms3000000454772838, createdTime=Sun Oct 26 21:51:54 CST 2025, time=2025-10-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2287004, encodeId=83c0228e00440, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信;干湿结合 经验分享：这个期刊真恶心，初审还让我改这改那的，又得上传原始数据到公共数据库，搞完返回去跟我说，文章被编辑部评估发表的优先度低拒稿了。你早点拒稿呀，让我搞这么多事干嘛，傻逼杂志，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb365528709, createdName=ms6000000058422661, createdTime=Fri Oct 31 19:17:36 CST 2025, time=2025-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2284369, encodeId=d97022843695f, content=不收BIB，拒稿邮件：BMC Cancer does not consider bibliometric analyses and therefore we cannot consider your manuscript for peer review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Sat Oct 11 11:14:20 CST 2025, time=2025-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269179, encodeId=ad8222691e90f, content=我这里的经验是peer review一个月后第一个审稿人接收，前面挺快的。看后面吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Jun 13 14:23:29 CST 2025, time=2025-06-13, status=1, ipAttribution=重庆)]

2025-10-31 ms6000000058422661 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;生信;干湿结合
经验分享：这个期刊真恶心，初审还让我改这改那的，又得上传原始数据到公共数据库，搞完返回去跟我说，文章被编辑部评估发表的优先度低拒稿了。你早点拒稿呀，让我搞这么多事干嘛，傻逼杂志，慎投。

212 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2366039, encodeId=27202366039d9, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：傻鸟杂志一审审了9个月，5个审稿人意见加起来有5000字, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d255482563, createdName=ms4000000366935454, createdTime=Wed Sep 09 14:11:03 CST 2026, time=2026-09-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2353301, encodeId=42a42353301ab, content=给了大修，修改后多久给决定意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Aug 06 19:43:00 CST 2026, time=2026-08-06, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2292693, encodeId=c508229269364, content=BMC接收纯生信的文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84649148489, createdName=ms8000000335270410, createdTime=Wed Dec 10 16:14:55 CST 2025, time=2025-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2341974, encodeId=b2c923419e483, content=审稿速度:12.0 偏重的研究方向：胃癌;微创手术 经验分享：想问下近期有人投BMC Cancer的ARTICLE吗？投了一篇胃癌手术相关的文章，7个月一审还没回来，发邮件每次回复的差不多，这个情况有什么建议吗？以前投过一次，也是审稿比较慢，但是半年的时候接收了，这个感觉太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Mon Jul 13 10:48:50 CST 2026, time=2026-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2310645, encodeId=e4d5231064589, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：meta分析还是蛮快的，感觉还是挺看文章方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90cc8530029, createdName=ms2000002074391176, createdTime=Wed May 06 21:22:59 CST 2026, time=2026-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2300952, encodeId=84c6230095278, content=偏重的研究方向：肿瘤 经验分享：效率低下的令人发指, peer review三个月没人接受审稿。跟编辑部发邮件（我还是用工作邮箱发的）,每次就是打太极, 道歉态度倒是很诚恳。推荐了reviewer过去也不处理。准备再等半个月就撤稿了。这杂志要是这么搞下去真的要完蛋了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Wed Feb 18 06:52:18 CST 2026, time=2026-02-18, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2286260, encodeId=5f4a22862605c, content=我投的这个杂志，2月投稿的，现在第三次外审，快9个月了。第三次只有一个审稿人。前两次都是大修。还能录取吗，等毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69d8427178, createdName=ms3000000454772838, createdTime=Sun Oct 26 21:51:54 CST 2025, time=2025-10-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2287004, encodeId=83c0228e00440, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信;干湿结合 经验分享：这个期刊真恶心，初审还让我改这改那的，又得上传原始数据到公共数据库，搞完返回去跟我说，文章被编辑部评估发表的优先度低拒稿了。你早点拒稿呀，让我搞这么多事干嘛，傻逼杂志，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb365528709, createdName=ms6000000058422661, createdTime=Fri Oct 31 19:17:36 CST 2025, time=2025-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2284369, encodeId=d97022843695f, content=不收BIB，拒稿邮件：BMC Cancer does not consider bibliometric analyses and therefore we cannot consider your manuscript for peer review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Sat Oct 11 11:14:20 CST 2025, time=2025-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269179, encodeId=ad8222691e90f, content=我这里的经验是peer review一个月后第一个审稿人接收，前面挺快的。看后面吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Jun 13 14:23:29 CST 2025, time=2025-06-13, status=1, ipAttribution=重庆)]

2025-10-11 匿名用户

不收BIB，拒稿邮件：BMC Cancer does not consider bibliometric analyses and therefore we cannot consider your manuscript for peer review.

145 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2366039, encodeId=27202366039d9, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：傻鸟杂志一审审了9个月，5个审稿人意见加起来有5000字, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d255482563, createdName=ms4000000366935454, createdTime=Wed Sep 09 14:11:03 CST 2026, time=2026-09-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2353301, encodeId=42a42353301ab, content=给了大修，修改后多久给决定意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Aug 06 19:43:00 CST 2026, time=2026-08-06, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2292693, encodeId=c508229269364, content=BMC接收纯生信的文章吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84649148489, createdName=ms8000000335270410, createdTime=Wed Dec 10 16:14:55 CST 2025, time=2025-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2341974, encodeId=b2c923419e483, content=审稿速度:12.0 偏重的研究方向：胃癌;微创手术 经验分享：想问下近期有人投BMC Cancer的ARTICLE吗？投了一篇胃癌手术相关的文章，7个月一审还没回来，发邮件每次回复的差不多，这个情况有什么建议吗？以前投过一次，也是审稿比较慢，但是半年的时候接收了，这个感觉太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Mon Jul 13 10:48:50 CST 2026, time=2026-07-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2310645, encodeId=e4d5231064589, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：meta分析还是蛮快的，感觉还是挺看文章方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90cc8530029, createdName=ms2000002074391176, createdTime=Wed May 06 21:22:59 CST 2026, time=2026-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2300952, encodeId=84c6230095278, content=偏重的研究方向：肿瘤 经验分享：效率低下的令人发指, peer review三个月没人接受审稿。跟编辑部发邮件（我还是用工作邮箱发的）,每次就是打太极, 道歉态度倒是很诚恳。推荐了reviewer过去也不处理。准备再等半个月就撤稿了。这杂志要是这么搞下去真的要完蛋了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Wed Feb 18 06:52:18 CST 2026, time=2026-02-18, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2286260, encodeId=5f4a22862605c, content=我投的这个杂志，2月投稿的，现在第三次外审，快9个月了。第三次只有一个审稿人。前两次都是大修。还能录取吗，等毕业啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69d8427178, createdName=ms3000000454772838, createdTime=Sun Oct 26 21:51:54 CST 2025, time=2025-10-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2287004, encodeId=83c0228e00440, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信;干湿结合 经验分享：这个期刊真恶心，初审还让我改这改那的，又得上传原始数据到公共数据库，搞完返回去跟我说，文章被编辑部评估发表的优先度低拒稿了。你早点拒稿呀，让我搞这么多事干嘛，傻逼杂志，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb365528709, createdName=ms6000000058422661, createdTime=Fri Oct 31 19:17:36 CST 2025, time=2025-10-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2284369, encodeId=d97022843695f, content=不收BIB，拒稿邮件：BMC Cancer does not consider bibliometric analyses and therefore we cannot consider your manuscript for peer review., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Sat Oct 11 11:14:20 CST 2025, time=2025-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269179, encodeId=ad8222691e90f, content=我这里的经验是peer review一个月后第一个审稿人接收，前面挺快的。看后面吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Jun 13 14:23:29 CST 2025, time=2025-06-13, status=1, ipAttribution=重庆)]

2025-06-13 148893c2m57(暂无昵称) 来自重庆

我这里的经验是peer review一个月后第一个审稿人接收，前面挺快的。看后面吧

145 2 举报

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务